Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-17T16:39:16.509Z Has data issue: false hasContentIssue false

4 - Hematological processes in emboli formation

from Background

Published online by Cambridge University Press:  03 December 2009

By
Alison H. Goodall  and
Greg McMahon
Edited by
Jonathan Gillard ,
Martin Graves ,
Thomas Hatsukami  and
Chun Yuan
Alison H. Goodall
Affiliation:
University of Leicester, Leicester, UK
Greg McMahon
Affiliation:
University of Leicester, Leicester, UK
Jonathan Gillard
Affiliation:
University of Cambridge
Martin Graves
Affiliation:
University of Cambridge
Thomas Hatsukami
Affiliation:
University of Washington
Chun Yuan
Affiliation:
University of Washington
Get access

Summary

Introduction

Spontaneous plaque rupture, or damage to the vessel wall during therapeutic interventions will lead to the formation of a thrombus at the site of vascular damage. Emboli can be released either as a result of shearing of the thrombus from the vessel wall, or as smaller emboli propagated at the surface of the growing thrombus. In either case the released emboli can lead to downstream vascular occlusion and subsequent ischemia.

Cerebrovascular events related to carotid artery disease are caused in the majority of cases by atherothrombotic emboli dislodging from the carotid plaque (Foulkes et al., 1988; Sitzer et al., 1995; Lammie et al., 1999; Jander et al., 2001). Embolization of platelet thrombus into the circulation is also a well recognized complication of surgical intervention (carotid endarterectomy) or carotid stenting (Riles et al., 1994; Jordan et al., 1999) and is the main cause of postoperative stroke and transient ischemic attack (TIA) (Spencer, 1997). It can generally be considered that embolization that occurs during the dissection phase of carotid endarterectomy is associated with carotid plaque instability, whereas embolic events observed after endarterectomy, following restoration of flow and in the early postoperative period, are related to excessive thrombus formation at the endarterectomy and clamping sites.

Keywords

antiplatelet therapyantithrombotic therapycarotid arteryembolizationthrombus stabilizationthrombus formation
Type
Chapter
Information
Carotid Disease
The Role of Imaging in Diagnosis and Management
 , pp. 45 - 58
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Anand, S. X., Viles-Gonzalez, J. F., Badimon, J. J., Cavusoglu, E. and Marmur, J. D. (2003). Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thrombosis & Haemostasis, 90, 377–84.Google ScholarPubMed
Andre, P., Delaney, S. M., LaRocca, T., et al. (2003). P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. Journal of Clinical Investigation, 112, 398–406.CrossRefGoogle ScholarPubMed
Angelillo-Scherrer, A., Frutos, P., Aparicio, C., et al. (2001). Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nature Medicine, 7, 215–21.CrossRefGoogle ScholarPubMed
Angelillo-Scherrer, A., Burnier, L., Flores, N., et al. (2005). Role of Gas6 receptors in platelet signalling during thrombus stabilization and implications for antithrombotic therapy. Journal of Clinical Investigation, 115, 237–56.CrossRefGoogle Scholar
Antithrombotic Trialists' Collaboration. (2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. British Medical Journal, 321, 71–86.
Ariens, R. A., Lai, T. S., Weisel, J. W., Greenberg, C. S. and Grant, P. J. (2002). Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood, 100, 743–54.CrossRefGoogle ScholarPubMed
Barnett, H. J., Eliasiw, M. and Meldrum, H. E. (1995). Drugs and surgery in the prevention of ischaemic stroke. New England Journal of Medicine, 332, 238–48.CrossRefGoogle Scholar
Baumgartner, H. R., Mannucci, P. M. and Meyer, D. (1994). The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease. British Journal of Haematology, 86, 327–32.Google Scholar
Blomback, B. (1994). Fibrinogen structure, activation, polymerization and fibrin gel structure. Thrombosis Research, 75, 327–8.CrossRefGoogle ScholarPubMed
Clopidogrel versus aspirin in patients at risk of ischemic events steering committee. (1996). A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet, 348, 1329–39.CrossRef
Carr, M. E.Hermans, J.Jr (1978). Size and density of fibrin fibers from turbidity. Macromolecules, 11, 46–50.CrossRefGoogle ScholarPubMed
Cattaneo, M., Canciani, M. T., Lecchi, A., et al. (1990). Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. Blood, 75, 1081–6.Google ScholarPubMed
Chandler, A. B. (1958). In vitro thrombotic coagulation of the blood. Laboratory Investigations, 7, 110–14.Google ScholarPubMed
Coller, B. S., Folts, J. D., Smith, S. R., Scudder, L. E. and Jordan, R. (1989). Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GlycoproteinIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GlycoproteinIIb/IIIa receptors. Circulation, 80, 1766–74.CrossRefGoogle Scholar
Collet, J. P., Lesty, C., Montalescot, G. and Weisel, J. W. (2003). Dynamic changes of fibrin architecture during fibrin formation and intrinsic fibrinolysis of fibrin-rich clots. Journal of Biological Chemistry, 278, 21331–5.CrossRefGoogle ScholarPubMed
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation investigators. (2001). Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. New England Journal of Medicine, 345, 494–502.CrossRef
Danesh, J., Lewington, S., Thompson, S. G., et al. (2005). Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. Journal of the American Medical Association, 294, 1799–809.Google ScholarPubMed
Day, S. M., Reeve, J. L., Myers, D. D. and Fay, W. P. (2004). Murine thrombosis models. Thrombosis & Haemostasis, 92, 486–94.Google ScholarPubMed
Day, S. M., Reeve, J. L., Pedersen, B., et al. (2005). Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood, 105, 192–8.CrossRefGoogle ScholarPubMed
DeClerck, P. J., Alessi, M. C., Verstreken, M., et al. (1988). Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood, 71, 220–5.Google ScholarPubMed
Doutremepuich, F., Aguejouf, O., Belougne-Malfatti, E. and Doutremepuich, C. (1998). Fibrinogen as a factor of thrombosis: experimental study. Thrombosis Research, 90, 57–64.CrossRefGoogle ScholarPubMed
Falati, S., Gross, P., Merrill-Skoloff, G., et al. (2002). Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nature Medicine, 8, 1175–81.CrossRefGoogle ScholarPubMed
Falati, S., Liu, Q., Gross, P., et al. (2003). Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine, 197, 1585–98.CrossRefGoogle ScholarPubMed
Fernandez-Ortiz, A., Badimon, J. J., Falk, E., et al. (1994). Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. Journal of the American College of Cardiology, 23, 1562–9.CrossRefGoogle ScholarPubMed
Folts, J. D., Crowell, , E. B. Jr, and Rowe, G. G. (1976). Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation, 54, 365–70.CrossRefGoogle Scholar
Fontana, P., Dupont, A., Gandrille, S., et al. (2003). Adenosine diphosphate-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects. Circulation, 108, 989–95.CrossRefGoogle ScholarPubMed
Foulkes, M. A., Wolf, P. A., Price, T. R., Mohr, J. P. and Hier, D. B. (1988). The Stroke Data Bank: design, methods, and baseline characteristics. Stroke, 19, 547–54.CrossRefGoogle ScholarPubMed
Furie, B., Furie, B. C. and Flaumenhaft, R. (2001). A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thrombosis & Haemostasis, 86, 214–21.CrossRefGoogle ScholarPubMed
Gachet, C. (2001). ADP receptors of platelets and their inhibition. Thrombosis & Haemostasis, 86, 222–32.Google ScholarPubMed
Gachet, C. and Hechler, B. (2005). The platelet P2 receptors in thrombosis. Seminars in Thrombosis & Hemostasis, 31, 162–7.CrossRefGoogle ScholarPubMed
Gaunt, M. E., Smith, J. L., Ratliff, D. A., Bell, P. R. and Naylor, A. R. (1996). A comparison of quality control methods applied to carotid endarterectomy. European Journal of Vascular & Endovascular Surgery, 11, 4–11.CrossRefGoogle ScholarPubMed
Geiger, J., Brich, J., Honig-Liedl, P., et al. (1999). Specific impairment of human platelet P2YAC ADP receptor- mediated signaling by the antiplatelet drug clopidogrel. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 2007–11.CrossRefGoogle Scholar
Geng, J. G., Chen, M., Chou, K. C. (2004). P-selectin cell adhesion molecule in inflammation, thrombosis, cancer growth and metastasis. Current Medicinal Chemistry, 11, 2153–60.CrossRefGoogle ScholarPubMed
Goertler, M., Baeumer, M., Kross, R., et al. (1999). Rapid decline of cerebral microemboli of arterial origin after intravenous acetylsalicylic acid. Stroke, 30, 66–9.CrossRefGoogle ScholarPubMed
Goldsmith, H. L. and Turitto, V. T. (1986). Rheological aspects of thrombosis and haemostasis: basic principles and applications. Computerized tomographyH-Report–Subcommittee on Rheology of the International Committee on Thrombosis and Haemostasis. Thrombosis & Haemostasis, 55, 415–35.Google Scholar
Golino, P., Ragni, M., and Cirillo, P., et al. (1995). Aurintricarboxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions. Thrombosis & Haemostasis, 74, 974–9.Google ScholarPubMed
Harker, L. A., Marzec, U. M., Kelly, A. B., et al. (1998). Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation, 98, 2461–9.CrossRefGoogle ScholarPubMed
Hass, W. K., Easton, J. D., Adams, H. P. J., et al. (1989). A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. New England Journal of Medicine, 321, 501–7.CrossRefGoogle ScholarPubMed
Hayes, P. D., Payne, D., Lloyd, A. J., Bell, P. R. and Naylor, A. R. (2001). Patients' thromboembolic potential between bilateral carotid endarterectomies remains stable over time. European Journal of Vascular & Endovascular Surgery, 22, 496–8.CrossRefGoogle ScholarPubMed
Hayes, P. D., Box, , H., Tull, S., et al. (2003). Patients' thromboembolic potential after carotid endarterectomy is related to the platelets' sensitivity to adenosine diphosphate. Journal of Vascular Surgery, 38, 1226–31.CrossRefGoogle ScholarPubMed
Hetherington, S. L., Singh, R. K., Lodwick, D., et al. (2005). Dimorphism in the P2RY1 ADP receptor gene is associated with increased platelet activation response to ADP. Arteriosclerosis, Thrombosis and Vascular Biology, 25, 252–7.Google Scholar
Hoffman, M. (2003). Remodelling the blood coagulation cascade. Journal of Thrombosis and Thrombolysis, 16, 17–20.CrossRefGoogle Scholar
Hoffman, M. and Monroe, D. M. 3rd. (2001). A cell-based model of hemostasis. Thrombosis & Haemostasis, 85, 958–65.Google ScholarPubMed
Ikeda, H., Ueyama, T., Murohara, T., et al. (1999). Adhesive interaction between P-selectin and sialyl Lewis(x) plays an important role in recurrent coronary arterial thrombosis in dogs. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 1083–90.CrossRefGoogle ScholarPubMed
Ingall, A. H., Dixon, J., Bailey, A., et al. (1999). Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. Journal of Medicinal Chemistry, 42, 213–20.CrossRefGoogle ScholarPubMed
Jander, S., Sitzer, M., Wendt, A., et al. (2001). Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke, 32, 850–4.CrossRefGoogle ScholarPubMed
Jin, J. and Kunapuli, S. P. (1998). Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proceedings of the New York Academy of Sciences UltrasoundA, 95, 8070–4.CrossRefGoogle ScholarPubMed
Jirouskova, M., Chereshnev, I., Vaananen, H., Degen, J. L. and Coller, B. S. (2004). Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood, 103, 1995–2002.CrossRefGoogle ScholarPubMed
Jordan, W. D., Voellinger, D. C., Doblar, D. D., et al. (1999). Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovascular Surgery, 7, 33–8.CrossRefGoogle ScholarPubMed
Junghans, U. and Siebler, M. (2003). Cerebral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation, 107, 2717–21.CrossRefGoogle ScholarPubMed
Kobbervig, C. and Williams, E. (2004). FXIII polymorphisms, fibrin clot structure and thrombotic risk. Biophysical Chemistry, 112, 223–8.CrossRefGoogle ScholarPubMed
Koenig, W. (2003). Fibrin(ogen) in cardiovascular disease: an update. Thrombosis & Haemostasis, 89, 601–9.Google ScholarPubMed
Konstanitinides, S., Scafer, K., Thinnes, T. and Loskutoff, D. J. (2001). Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation, 103, 576–83.CrossRefGoogle Scholar
Koschnick, S., Konstanitinides, S., Scafer, K., Crain, K. and Loskutoff, D. J. (2005). Thrombotic phenotype of mice with a combined deficiency in plasminogen activator inhibitor 1 and vitronectin. Journal of Thrombosis & Haemostasis, 3, 2290–5.CrossRefGoogle ScholarPubMed
Lammie, G. A., Sandercock, P. A. and Dennis, M. S. (1999). Recently occluded intracranial and extracranial carotid arteries: relevance of the unstable atherosclerotic plaque. Stroke, 30, 1319–25.CrossRefGoogle ScholarPubMed
Larsen, E. A., Celi, G. E., Gilbert, B. C., et al. (1989). PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell, 59, 305–12.CrossRefGoogle ScholarPubMed
Lefkovits, J., Plow, E. F. and Topol, E. J. (1995). Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. New England Journal of Medicine, 332, 1553–9.CrossRefGoogle ScholarPubMed
Lentz, B. R. (2003). Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Progress in Lipid Research, 42, 423–38.CrossRefGoogle ScholarPubMed
Leon, C., Freund, M., Ravanat, C., et al. (2001). Key role of the P2Y1 receptor in tissue factor induced thrombin dependent acute thromboembolism. Studies in P2Y1 knockout mice and mice treated with a P2Y1 antagonist. Circulation, 103, 718–23.CrossRefGoogle Scholar
Lijnen, H. R. and Collen, D. (1997). Endothelium in hemostasis and thrombosis. Progress in Cardiovascular Diseases, 39, 343–50.CrossRefGoogle ScholarPubMed
Mackman, N. (2004). Mouse models in haemostasis and thrombosis. Thrombosis & Haemostasis, 92, 440–3.Google ScholarPubMed
McEver, R. P., Beckstead, , J. H., Moore, , K. L., Marshall-Carlson, L. and Bainton, D. F. (1989). GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. Journal of Clinical Investigation, 84, 92–9.CrossRefGoogle ScholarPubMed
Markus, H. S., Droste, D. W., Kaps, M., et al. (2005). Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (Clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis) trial. Circulation, 111, 2233–40.CrossRefGoogle ScholarPubMed
Merten, M. and Thiagarajan, P. (2000). P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation, 102, 1931–6.CrossRefGoogle ScholarPubMed
Morgenstern, E., Gnad, U., Preissner, K. T., et al. (2001). Localization of protein kinase A and vitronectin in resting platelets and their translocation onto fibrin fibers during clot formation. European Journal of Cell Biology, 80, 87–98.CrossRefGoogle ScholarPubMed
Morrissey, J. H., Macik, B. G., Neuenschwander, P. F. and Comp, P. C. (1993). Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood, 81, 734–44.Google ScholarPubMed
Naylor, A. R., Hayes, P. D., Allroggen, H., et al. (2000). Reducing the risk of carotid surgery: A seven-year audit of the role of monitoring and quality control assessment. Journal of Vascular Surgery, 32, 750–9.CrossRefGoogle Scholar
Ni, H., Denis, C. V., Subbarao, S., et al. (2000). Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. Journal of Clinical Investigation, 106, 385–92.CrossRefGoogle ScholarPubMed
Ni, H., Ramakrishnan, V., Ruggeri, Z. M., et al. (2001). Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood, 98, 368–73.CrossRefGoogle ScholarPubMed
Ni, H., Papalia, J. M., Degen, J. L. and Wagner, D. D. (2003). Control of thrombus embolization and fibronectin internalization by integrin alpha IIb beta 3 engagement of the fibrinogen gamma chain. Blood, 102, 3609–14.CrossRefGoogle ScholarPubMed
O'Donnell, C. J., Larson, M. G., Feng, D., et al. (2001). Framingham Heart Study. Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation, 103, 3051–6.CrossRefGoogle ScholarPubMed
oude Egbrink, M. G., Tangelder, G. J., Slaaf, D. W. and Reneman, R. S. (1993). Different roles of prostaglandins in thromboembolic processes in arterioles and venules in vivo. Thrombosis & Haemostasis, 70, 826–33.Google ScholarPubMed
Parise, L. V. (1999). Integrin alpha(IIb)beta(3) signalling in platelet adhesion and aggregation. Current Opinion in Cell Biology, 11, 597–601.CrossRefGoogle Scholar
Payne, D. A., Jones, C. I., Hayes, P. D., et al. (2004). Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation, 109, 1476–81.CrossRefGoogle ScholarPubMed
Prasad, K. S., Andre, P., He, M., et al. (2004). Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling. Proceedings of the National Academy of Sciences of the United States of America, 100, 12367–71.CrossRefGoogle Scholar
Preissner, K. T. (1991). Structure and biological role of vitronectin. Annual Review of Cell Biology, 7, 275–310.CrossRefGoogle ScholarPubMed
Prevost, N., Woulfe, D. S., Jiang, H., et al. (2005). Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proceedings of the National Academy of Sciences of the United States of America, 102, 9820–5.CrossRefGoogle ScholarPubMed
Quinn, M. J., Byzova, T. V., Qin, J., Topol, E. J. and Plow, E. F. (2003). Integrin alphaIIbbeta3 and its antagonism. Arteriosclerosis, Thrombosis and Vascular Biology, 23, 945–52.CrossRefGoogle ScholarPubMed
Reheman, A., Gross, P., Yang, H., et al. (2005). Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. Journal of Thrombosis & Haemostasis, 3, 875–83.CrossRefGoogle Scholar
Riles, T. S., Imparato, A. M., Jacobowitz, G. R., et al. (1994). The cause of perioperative stroke after carotid endarterectomy. Journal of Vascular Surgery, 19, 206–14.CrossRefGoogle ScholarPubMed
Robbie, L. A., Young, S. P., Bennett, B. and Booth, N. A. (1997). Thrombi formed in a Chandler loop mimic human arterial thrombi in structure and Plasminogen inhibitor type-1 content and distribution. Thrombosis & Haemostasis, 77, 510–15.Google Scholar
Ruggeri, Z. M. (1997). Mechanisms initiating platelet thrombus formation. Thrombosis & Haemostasis, 78, 611–16.Google ScholarPubMed
Ruggeri, Z. M., Dent, J. A. and Saldivar, E. (1999). Contribution of distinct adhesive interactions to platelet aggregation in flowing blood. Blood, 94, 172–8.Google ScholarPubMed
Sakariassen, K. S., Muggli, R. and Baumgartner, H. R. (1989). Measurements of platelet interaction with components of the vessel wall in flowing blood. Methods in Enzymology, 169, 37–70.CrossRefGoogle ScholarPubMed
Sakariassen, K. S., Turitto, V. T. and Baumgartner, H. R. (2004). Recollections of the development of flow devices for studying mechanisms of hemostasis and thrombosis in flowing whole blood. Journal of Thrombosis & Haemostasis, 2, 1681–90.CrossRefGoogle ScholarPubMed
Samama, C. M., Bonnin, P., Bonneau, M., et al. (1992). Comparative arterial antithrombotic activity of clopidogrel and acetyl salicylic acid in the pig. Thrombosis & Haemostasis, 68, 500–5.Google ScholarPubMed
Savage, B., Cattaneo, M. and Ruggeri, Z. M. (2001). Mechanisms of platelet aggregation. Current Opinions in Hematology, 8, 270–6.CrossRefGoogle ScholarPubMed
Scott, E. M., Ariens, R. A. and Grant, P. J. (2004). Genetic and environmental determinants of fibrin structure and function: relevance to clinical disease. Arteriosclerosis, Thrombosis and Vascular Biology, 24, 1558–66.CrossRefGoogle ScholarPubMed
Sim, D., Flaumenhaft, R. and Furie, B. (2005). Interactions of platelets, blood-borne tissue factor, and fibrin during arteriolar thrombus formation in vivo. Microcirculation, 12, 301–11.CrossRefGoogle ScholarPubMed
Simpson, A. J., Booth, N. A., Moore, N. R. and Bennett, B. (1990). The platelet and plasma pools of plasminogen activator inhibitor (Plasminogen inhibitor type-1) vary independently in disease. British Journal of Haematology, 75, 543–8.CrossRefGoogle Scholar
Sitzer, M., Muller, W., Siebler, M., et al. (1995). Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke, 26, 1231–3.CrossRefGoogle ScholarPubMed
Spencer, M. P. (1997). Transcranial Doppler monitoring and causes of stroke from carotid endarterectomy. Stroke, 28, 685–91.CrossRefGoogle ScholarPubMed
Storey, R. F. (2001). The P2Y12 receptor as a therapeutic target in cardiovascular disease. Platelets, 12, 197–209.CrossRefGoogle ScholarPubMed
Storey, R. F., Oldroyd, K. G. and Wilcox, R. G. (2001). Open multicentre study of the P2T receptor antagonist AR-C69931 MX assessing safety, tolerability and activity in patients with acute coronary syndromes. Thrombosis & Haemostasis, 85, 401–7.Google Scholar
Topol, E. J., Byzova, T. V. and Plow, E. F. (1999). Platelet Glycoprotein IIb/IIIa blockers. Lancet, 353, 227–31.CrossRefGoogle Scholar
Tschopp, T. B., Baumgartner, H. R., Silberbauer, K. and Sinzinger, H. (1979). Platelet adhesion and platelet thrombus formation on subendothelium of human arteries and veins exposed to flowing blood in vitro. A comparison with rabbit aorta. Haemostasis, 8, 19–29.Google ScholarPubMed
Tsuji, S., Sugimoto, M., Miyata, S., et al. (1999). Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood, 94, 968–75.Google ScholarPubMed
Ueyama, T., Ikeda, H., Haramaki, N., Kuwano, K. and Imaizumi, T. (1997). Effects of monoclonal antibody to P-selectin and analogue of sialyl Lewis X on cyclic flow variations in stenosed and endothelium-injured canine coronary arteries. Circulation, 95, 1554–9.CrossRefGoogle ScholarPubMed
Gestel, M. A., Heemskerk, J. W., Slaaf, D. W., et al. (2002). Real-time detection of activation patterns in individual platelets during thromboembolism in vivo: differences between thrombus growth and embolus formation. Journal of Vascular Research, 39, 534–43.CrossRefGoogle ScholarPubMed
Gestel, M. A., Heemskerk, J. W., Slaaf, D. W., et al. (2003). In vivo blockade of platelet ADP receptor P2Y12 reduces embolus and thrombus formation but not thrombus stability. Arteriosclerosis, Thrombosis and Vascular Biology, 23, 518–23.CrossRefGoogle Scholar
Vaughan, D. E. (2005). Plasminogen inhibitor type-1 and atherothrombosis. Journal of Thrombosis & Haemostasis, 3, 1879–83.CrossRefGoogle Scholar
Vorchheimer, D. A., Badimon, J. J. and Fuster, V. (1999). Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. Journal of the American Medical Association, 281, 1407–14.CrossRefGoogle ScholarPubMed
Weisel, J. W. (2005). Fibrinogen and fibrin. Advances in Protein Chemistry, 70, 247–99.CrossRefGoogle ScholarPubMed
Wilcox, J. N., Smith, K. M., Schwartz, S. M., et al. (1989). Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proceedings of the National Academy of Sciences UltrasoundA, 86, 2839–43.CrossRefGoogle Scholar
Wolberg, A. S., Monroe, D. M., Roberts, H. R. and Hoffman, M. (2003). Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk. Blood, 101, 3008–13.CrossRefGoogle ScholarPubMed
Woulfe, D., Yang, J. and Brass, L. (2001). ADP and platelets: the end of the beginning. Journal of Clinical Investigation, 107, 1503–5.CrossRefGoogle ScholarPubMed
Yao, S. K., Ober, J. C., Krishnaswami, A., et al. (2002). Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation, 86, 1302–9.CrossRefGoogle Scholar
Yokoyama, S., Ikeda, H., Haramaki, N., et al. (2005). Platelet P-selectin plays an important role in arterial thrombogenesis by forming large stable platelet-leukocyte aggregates. Journal of the American College of Cardiology, 45, 1280–6.CrossRefGoogle ScholarPubMed
Zwaal, R. F. and Schroit, A. J. (1997). Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood, 89, 1121–32.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×